| Progress on modulating tumor‐associated macrophages with biomaterials M Sylvestre, CA Crane, SH Pun Advanced Materials 32 (13), 1902007, 2020 | 126 | 2020 |
| Spatiotemporal targeting of a dual-ligand nanoparticle to cancer metastasis E Doolittle, PM Peiris, G Doron, A Goldberg, S Tucci, S Rao, S Shah, ... ACS nano 9 (8), 8012-8021, 2015 | 123 | 2015 |
| Vascular targeting of a gold nanoparticle to breast cancer metastasis PM Peiris, P Deb, E Doolittle, G Doron, A Goldberg, P Govender, S Shah, ... Journal of pharmaceutical sciences 104 (8), 2600-2610, 2015 | 56 | 2015 |
| Design of polymeric carriers for intracellular peptide delivery in oncology applications S Lv, M Sylvestre, AN Prossnitz, LF Yang, SH Pun Chemical reviews 121 (18), 11653-11698, 2021 | 52 | 2021 |
| Serum nuclease susceptibility of mRNA cargo in condensed polyplexes A Yen, Y Cheng, M Sylvestre, HH Gustafson, S Puri, SH Pun Molecular Pharmaceutics 15 (6), 2268-2276, 2018 | 47 | 2018 |
| Development of D-melittin polymeric nanoparticles for anti-cancer treatment S Lv, M Sylvestre, K Song, SH Pun Biomaterials 277, 121076, 2021 | 38 | 2021 |
| Well‐Defined Mannosylated Polymer for Peptide Vaccine Delivery with Enhanced Antitumor Immunity S Lv, K Song, A Yen, DJ Peeler, DC Nguyen, A Olshefsky, M Sylvestre, ... Advanced healthcare materials 11 (9), 2101651, 2022 | 28 | 2022 |
| Replacement of L-amino acid peptides with D-amino acid peptides mitigates anti-PEG antibody generation against polymer-peptide conjugates in mice M Sylvestre, S Lv, LF Yang, N Luera, DJ Peeler, BM Chen, SR Roffler, ... Journal of controlled release 331, 142-153, 2021 | 23 | 2021 |
| Current state of in vivo panning technologies: Designing specificity and affinity into the future of drug targeting HH Gustafson, A Olshefsky, M Sylvestre, DL Sellers, SH Pun Advanced drug delivery reviews 130, 39-49, 2018 | 20 | 2018 |
| Identification of a DNA aptamer that binds to human monocytes and macrophages M Sylvestre, CP Saxby, N Kacherovsky, H Gustafson, SJ Salipante, ... Bioconjugate Chemistry 31 (8), 1899-1907, 2020 | 14 | 2020 |
| Reversibly switchable, pH-dependent peptide ligand binding via 3, 5-diiodotyrosine substitutions C Ngambenjawong, M Sylvestre, HH Gustafson, JMB Pineda, SH Pun ACS Chemical Biology 13 (4), 995-1002, 2018 | 9 | 2018 |
| A Facile cyclization method Improves peptide serum stability and confers intrinsic fluorescence C Ngambenjawong, HH Gustafson, M Sylvestre, SH Pun ChemBioChem 18 (24), 2395-2398, 2017 | 5 | 2017 |
| In vivo selection of synthetic nucleocapsids for tissue targeting A Olshefsky, H Benasutti, M Sylvestre, GL Butterfield, GJ Rocklin, ... Proceedings of the National Academy of Sciences 120 (46), e2306129120, 2023 | 1 | 2023 |
| Engineering pH-Responsive Biomaterials for Cancer Immunotherapy M Sylvestre University of Washington, 2021 | 1 | 2021 |
| Discovery and preclinical characterization of dual antagonist antibodies targeting both LILRB1 and LILRB2 that enhance innate and adaptive anti-cancer immune responses M Zuck, M Bouchlaka, H Dinh, K Green, F Zapata, R Chandrasekaran, ... Cancer Research 83 (7_Supplement), 6376-6376, 2023 | | 2023 |
| Monocyte and macrophage binding aptamers and their application SH Pun, M Sylvestre, N Kacherovsky, E Cheng, I Cardle, C Saxby US Patent App. 17/849,513, 2023 | | 2023 |
| Modular reprogramming of designed protein nanoparticles to selectively target solid tumors AE Olshefsky, GL Butterfield, MJ Lajoie, E Leaf, C Treichel, E Nunes, ... Modular engineering and in vivo library selection of tissue-targeting …, 2023 | | 2023 |
| Preclinical characterization of OR502, an anti-LILRB2 antibody that rescues innate and adaptive immune responses from LILRB2 mediated immune suppression M Zuck, M Bouchlaka, H Dinh, K Green, M Sylvestre, F Zapata, ... Journal for ImmunoTherapy of Cancer 10, A519-A519, 2022 | | 2022 |
